Russian Pharmaceutical Industry Leader

Research and Development

Scientific activities

Our main research goal is to develop innovative medicines. The most important are the new pharmaceutically active substances which envelop the new principles of disease treatment.

The closest attention is paid to the innovations which are supposed to give new pharmacokinetic properties to the already known medicines.

Major effort has been put into the avenues of research which are the most significant for the company. We work on new molecules for the treatment of such diseases as tuberculosis, oncopathology, HIV.

In recent years the range of interests has considerably expanded

We conduct research to create new antibiotics and biotechnological products both independently, and in cooperation with other research collectives.

We are open for partnership and are ready to discuss cooperation proposals.

Developments in the stage of clinical trials and registration

The Pharmasyntez company in cooperation with the Irkutsk Institute of Chemistry SB RAS developed the original medicine for the treatment of multiple drug resistance tuberculosis (MDRTB) – Perchlozone®.

This medicine is the first innovative tuberculosis treatment in the last 40 years. Perchlozone® was registered and introduced to the market in 2012 after successful clinical testing. Nowadays the IV phase of clinical testing is conducted.


In 2012 the Pharmasyntez company in cooperation with the Irkutsk Scientific Center of Surgery and Traumatology developed medicine for postoperative adhesions prevention – Seroguard®.

The preclinical testing and the first phase of clinical trials were successfully carried out with the assistance of the Russian Federation Ministry of Industry and Trade.

Showing a safety profile similar to placebo Seroguard® entered the second phase of clinical trials.

Once these clinical trials are successfully completed, surgeons of various specialties will receive the medicine with unique features. It will aim to prevent postoperative complications which are almost inevitable now.

Participation in scientific conferences
  • 2010
  • 2011
  • 2012
  • 2014
  • 2015
  • 2016
  • 2017
  • 2010

    • June 28-29, Moscow, Scientific and practical conference "Topical Issues of Tuberculosis Prevention, Diagnostics and Treatment"
    • October 21-23, St. Petersburg, Russian scientific and practical conference with the international participation "A way of enhancement of medical care by the TB patient"

  • 2011

    • May 11-12, St. Petersburg, Scientific and Practical Conference "Innovative Technologies in Phthisiology and Pulmonology"
    • June 1-3, Moscow, IX Congress of Phthisiatricians of Russia
    • August 25-26, Scientific and Practical Conference "Current Problems of Antituberculous Care and Prospect of Its Enhancement"
    • October 20-22, St. Petersburg, Scientific and Practical Conference "Enhancement of Medical Care by the TB Patient"
    • November 16-18, Omsk, All-Russian Scientific and Practical Conference "Social Aspects of a Problem of Children's Tuberculosis"

  • 2012

    • St. Petersburg, I Congress of National association of phthisiatricians

  • 2014

    • June 17-19, St. Petersburg, Russian Pharmaceutical Forum of the Adam Smith Institute
    • August 22, Petropavlovsk-Kamchatsky, Regional scientific and practical conference "Issues of Phthisiology of the Adults and Children"
    • IV Eastern Europe and Central Asia HIV/AIDS Conference

  • 2015

    • June 18 2015, Philadelphia, PA, BIO International Convention 2015
    • May 4-6, Tashkent, VIII congress of phthisiatricians and pulmonologists of Uzbekistan

  • 2016

    • March 23-25, Moscow, The fifth International Conference on HIV/AIDS in Eastern Europe and Central Asia
    • June 6-9, 2016, San Francisco, CA, BIO International Convention 2016

  • 2017

    • February 20-24, 2017, Irkutsk, School conference with the international participation "V Scientific readings dedicated to the academician A.E. Favorskii"
    • May 15-19, 2017, Irkutsk, The Baikal school conference in chemistry